VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer
Clinical trial NCT05374538 · TERMINATED
Trial details
- NCT number
- NCT05374538
- Sponsor
- Vitrac Therapeutics, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-09
- Primary completion
- 2023-08-26
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.